134 related articles for article (PubMed ID: 2698488)
21. [The immunosuppressive therapy of chronic (Bright's) nephritis].
Krasnova TN; Shilov EM
Ter Arkh; 1993; 65(6):88-93. PubMed ID: 8378860
[No Abstract] [Full Text] [Related]
22. Membranous nephropathy--still a treatment dilemma.
Cameron JS
N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
[No Abstract] [Full Text] [Related]
23. [The treatment of patients with idiopathic membranous glomerulonephritis with cyclosporin A].
Tishkov I; Mushmov D; Milkov V; Lazarov V; Rapundzhieva A
Vutr Boles; 1989; 28(4):104-6. PubMed ID: 2596078
[No Abstract] [Full Text] [Related]
24. Effective treatment administration of cyclophosphamide in membranous nephropathy.
Dede F; Ayili D; Sahiner S
J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546
[TBL] [Abstract][Full Text] [Related]
25. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. VI. Encorton, immuran and cyclophosphamide].
Tyszkiewicz Z; Gawlik Z; Lewandowska T; Juska D
Patol Pol; 1984; 35(1):105-14. PubMed ID: 6493817
[No Abstract] [Full Text] [Related]
26. [Present possibilities of treatment of primary chronic glomerulonephritis].
Knotková V; Nĕmecek K
Vnitr Lek; 1994 Jun; 40(6):345-8. PubMed ID: 8073642
[TBL] [Abstract][Full Text] [Related]
27. Prognosis and management of membraneous nephropathy.
Pahari DK; Das S; Dutta BN; Banerjee D
J Assoc Physicians India; 1993 Jun; 41(6):350-1. PubMed ID: 8005970
[TBL] [Abstract][Full Text] [Related]
28. Membranoproliferative glomerulonephritis type II in a 10-year-old girl.
Tibbs ME; Andreoli SP; Phillips CL
Clin Lab Sci; 2005; 18(2):84-9. PubMed ID: 15916240
[TBL] [Abstract][Full Text] [Related]
29. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. III. Rapidly progressing glomerulonephritis and the use of converting enzyme inhibitors and non-steroidal anti-inflammatory drugs in idiopathic nephrotic syndrome].
Klinger M; Szewczyk Z
Przegl Lek; 1989; 46(11):779-83. PubMed ID: 2623185
[No Abstract] [Full Text] [Related]
30. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
31. Effects of combined immunosuppressive, anticoagulant and antiaggregant treatment on the course of chronic membranoproliferative glomerulonephritis.
Dimitrakov D; Simeonov S; Despotov T; Kumchev E; Tsvetkova Z
Folia Med (Plovdiv); 1991; 33(4):36-9. PubMed ID: 1669040
[No Abstract] [Full Text] [Related]
32. Choosing treatment for proliferative lupus nephritis.
Balow JE
Arthritis Rheum; 2002 Aug; 46(8):1981-3. PubMed ID: 12209498
[No Abstract] [Full Text] [Related]
33. Immunosuppression for membranous nephropathy.
Lancet; 1989 Jan; 1(8631):211-2. PubMed ID: 2563109
[No Abstract] [Full Text] [Related]
34. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[TBL] [Abstract][Full Text] [Related]
36. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
Hofstra JM; Wetzels JF
Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961
[TBL] [Abstract][Full Text] [Related]
37. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
38. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR
N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication.
Sayarlioglu H; Erkoc R; Dogan E; Sayarlioglu M; Topal C
Ann Pharmacother; 2005 Mar; 39(3):573. PubMed ID: 15671086
[No Abstract] [Full Text] [Related]
40. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
Imbasciati E; Cagnoli L; Case N; Pasquali S; Di Filippo G; Limido D; Cornalba L; Volpini T; Pozzi C; Zuccelli P; Ponticelli C
Minerva Nefrol; 1980; 27(4):571-5. PubMed ID: 7019771
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
